Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $974.47 | 72 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $625.81 | 50 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $87.27 | 7 | $0 (2018) |
| ABBVIE INC. | $50.92 | 2 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $38.62 | 2 | $0 (2023) |
| Allergan Inc. | $33.84 | 2 | $0 (2018) |
| ARBOR PHARMACEUTICALS, INC. | $30.04 | 2 | $0 (2018) |
| SI-BONE, Inc. | $20.51 | 1 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $17.87 | 1 | $0 (2018) |
| Coloplast Corp | $16.85 | 1 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $15.56 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.37 | 1 | ABBVIE INC. ($26.37) |
| 2023 | $63.17 | 3 | Amneal Pharmaceuticals LLC ($38.62) |
| 2021 | $90.75 | 4 | PFIZER INC. ($90.75) |
| 2020 | $101.87 | 5 | PFIZER INC. ($85.02) |
| 2019 | $213.28 | 17 | PFIZER INC. ($201.33) |
| 2018 | $268.01 | 23 | PFIZER INC. ($131.90) |
| 2017 | $211.02 | 19 | PFIZER INC. ($116.81) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/13/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: NEUROLOGY | ||||||
| 08/25/2023 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: NEUROLOGY | ||||||
| 08/09/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/24/2021 | PFIZER INC. | REYVOW (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/07/2021 | PFIZER INC. | REYVOW (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/10/2021 | PFIZER INC. | REYVOW (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/27/2021 | PFIZER INC. | REYVOW (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/02/2020 | PFIZER INC. | FLECTOR (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 08/28/2020 | PFIZER INC. | FLECTOR (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 07/15/2020 | PFIZER INC. | FLECTOR (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 05/08/2020 | PFIZER INC. | LYRICA (Drug), FLECTOR | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/14/2020 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $16.85 | General |
| Category: CONTINENCE | ||||||
| 11/15/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/13/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/21/2019 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/21/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 06/13/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/16/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/02/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/30/2019 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/15/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/22/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/01/2019 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/22/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,240 | 2,229 | $282,003 | $132,290 |
| 2022 | 17 | 1,376 | 2,323 | $322,393 | $145,406 |
| 2021 | 15 | 1,343 | 2,377 | $323,749 | $149,424 |
| 2020 | 15 | 1,387 | 2,334 | $306,814 | $141,702 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 228 | 541 | $56,805 | $31,802 | 56.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 394 | 860 | $55,900 | $31,520 | 56.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 124 | 208 | $41,600 | $14,323 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 133 | $19,950 | $11,419 | 57.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 88 | 92 | $18,400 | $8,812 | 47.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 78 | 79 | $12,719 | $6,342 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 89 | $8,900 | $5,481 | 61.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 26 | 26 | $15,600 | $4,924 | 31.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 37 | 37 | $12,950 | $3,145 | 24.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 28 | 28 | $11,200 | $3,116 | 27.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 20 | 20 | $9,000 | $3,108 | 34.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 34 | $4,930 | $3,031 | 61.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $5,000 | $1,823 | 36.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 29 | 29 | $3,277 | $1,714 | 52.3% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 16 | 16 | $4,800 | $1,309 | 27.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 12 | $972.00 | $422.73 | 43.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 235 | 455 | $47,775 | $23,929 | 50.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 143 | 311 | $45,095 | $23,729 | 52.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 370 | 720 | $46,800 | $20,338 | 43.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 130 | 207 | $41,400 | $15,008 | 36.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 101 | 102 | $29,070 | $14,884 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 148 | $22,200 | $12,473 | 56.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 100 | 102 | $16,422 | $8,012 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 89 | $8,900 | $5,574 | 62.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 23 | 23 | $13,800 | $4,917 | 35.6% |
About Dr. Michael Brown, MD
Dr. Michael Brown, MD is a Rehabilitation Practitioner healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063444974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Brown, MD has received a total of $974.47 in payments from pharmaceutical and medical device companies, with $26.37 received in 2024. These payments were reported across 72 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($974.47).
As a Medicare-enrolled provider, Brown has provided services to 5,346 Medicare beneficiaries, totaling 9,263 services with total Medicare billing of $568,822. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Rehabilitation Practitioner
- Other Specialties Physical Medicine & Rehabilitation
- Location Oklahoma City, OK
- Active Since 07/07/2006
- Last Updated 12/18/2013
- Taxonomy Code 225400000X
- Entity Type Individual
- NPI Number 1063444974
Products in Payments
- LYRICA (Drug) $412.94
- REYVOW (Drug) $90.75
- NUEDEXTA (Drug) $87.27
- FLECTOR (Drug) $63.37
- BOTOX (Biological) $50.92
- LYVISPAH (Drug) $38.62
- BOTOX THERAPEUTIC (Biological) $33.84
- ELIQUIS (Drug) $32.13
- Horizant (Drug) $30.04
- iFuse Implant (Device) $20.51
- XTAMPZA (Drug) $17.87
- SPEEDICATH (Device) $16.85
- SPECTRA WAVEWRITER (Device) $15.56
- EMBEDA (Drug) $14.12
- Superion ISS (Device) $14.04
- CHANTIX (Drug) $12.50
- Reveal LINQ (Device) $11.95
- OXYCONTIN (Drug) $11.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rehabilitation Practitioner Doctors in Oklahoma City
Dr. Christopher Bouvette, Md, MD
Rehabilitation Practitioner — Payments: $1,237
Albert Bisson, Md, MD
Rehabilitation Practitioner — Payments: $891.83
Dr. Kimberly Bouvette, Md, MD
Rehabilitation Practitioner — Payments: $838.41
Mr. Jacob Germany
Rehabilitation Practitioner
Mrs. Norma Johnson
Rehabilitation Practitioner
Julius Akhigbe, Mhr, Bhrs, MHR, BHRS
Rehabilitation Practitioner